Atorvastatin
Sold as Lipitor, Ran-atorvastatin, Atorvastatin sun, Lipogen, Atorvastatin unimed, Orbeos, Dynator, Atorvastatin viatris, Atorvastatin winthrop, Aspavor, Restan-atorvastatin, Adco atorvastatin, Alcholtin, Astor, Lestavor, Atorvastatin LHC, Vastor, Dezzolip, Alipto, Xalipmin, Cholmin, Lipred, Atorvastatin alkem
(3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
Drag to rotate. Structure from PubChem CID 60823.
Background
Registration
- Applicants
- 15
- Registrations
- 85
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Viatris Healthcare (Pty) Ltd | Lipitor, Vastor | 10 mg, 20 mg, 40 mg, 80 mg | 310358, 310359, 370210, 450527, 450528, 450529, 450530 | S4 | PIPIL |
| Ranbaxy (SA) (Pty) LtdCancelled | Ran-atorvastatin | 10, 20, 40, 80 | 420548, 420549, 420550, 420551 | Not determined | None |
| Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd | Atorvastatin sun, Lipogen | 10, 10/20/40/80 mg, 20, 40, 80 | 420552, 420553, 420554, 420555, 420556, 420557, 420558, 420559 | S4 | PIPIL |
| Unimed Healthcare (Pty) Ltd | Atorvastatin unimed, Alipto | 10, 10/ 20/ 40/ 80mg, 20, 40, 80 | 420926, 420927, 420928, 420929, 481206, 481207, 481208, 481209 | Not determined | PIPIL |
| Viatris South Africa (Pty) Ltd4 of 7 cancelled | Orbeos, Atorvastatin viatris | 10, 20, 40, 80 | 421050, 421051, 421052, 430222, 430223, 430224, 430838 | S4 | PIPIL |
| Pharma Dynamics (Pty) Ltd | Dynator | 10 mg, 20 mg, 40 mg, 80 mg | 430167, 430168, 430169, 430170 | Not determined | None |
| Sanofi-aventis South Africa (Pty) LtdCancelled | Atorvastatin winthrop | 10 mg, 20 mg, 40 mg | 430480, 430481, 430482 | Not determined | None |
| Upjohn South Africa (Pty) LtdCertificate held by Viatris South Africa (Pty) Ltd | Aspavor, Atorvastatin viatris | 10, 20, 40, 80 | 430837, 430839, A390017, A390018, A390019 | S4 | PIPIL |
| Adcock ingram limitedCancelled | Restan-atorvastatin, Adco atorvastatin, Alcholtin | 10 mg, 20 mg, 40 mg | 431113, 431114, 431115, 431116, 431117, 431118, 431119, 431120, 431121 | Not determined | None |
| Teva Pharmaceuticals (Pty) Ltd | Astor | 10/20/40/80 mg | 441054, 441055, 441056, 441057 | S4 | PIPIL |
| Activo Health (Pty) Ltd | Lestavor | 10, 20, 40, 80 | 441058, 441059, 441060, 441061 | Not determined | PIPIL |
| LHC Pharmaceuticals (Pty) Ltd | Atorvastatin LHC | 10, 20 | 450447, 450448 | Not determined | PIPIL |
| Unicorn Pharmaceuticals (Pty) Ltd | Dezzolip | 10mg/20mg/40mg/80mg | 481202, 481203, 481204, 481205 | S4 | PIPIL |
| Trinity Pharma (Pty) LtdCertificate held by Trinity Pharma (Pty) Ltd. | Xalipmin, Cholmin, Lipred | 0/20/40/80 mg, 10/20/40/80 mg | 490477, 490478, 490479, 490480, 490481, 490482, 490483, 490484, 490485, 490486, 490487, 490488 | S4 | PIPIL |
| Ascend Laboratories (Pty) Ltd | Atorvastatin alkem | 10 mg, 20 mg, 40 mg, 80 mg | 550608, 550609, 550610, 550611 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Lipitor 20 EACH TABLET CONTAINS ATORVASTATIN CALCIUM EQUIVALENT TO 20,0 mg ATORVASTATIN | 20Tablet | 31035831/7.5/0358Approved 22 October 2025 | Registered | S4 | PIPIL |
| Lipitor 40 EACH TABLET CONTAINS ATORVASTATIN CALCIUM EQUIVALENT TO 40,0 mg ATORVASTATIN | 40Tablet | 31035931/7.5/0359Approved 22 October 2025 | Registered | S4 | PIPIL |
| Lipitor 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80Tablet | 37021037/7.5/0210Approved 22 October 2025 | Registered | S4 | PIPIL |
| Ran-atorvastatin 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10 | 42054842/7.5/0548 | Cancelled | Not determined | None |
| Ran-atorvastatin 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20 | 42054942/7.5/0549 | Cancelled | Not determined | None |
| Ran-atorvastatin 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40 | 42055042/7.5/0550 | Cancelled | Not determined | None |
| Ran-atorvastatin 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80 | 42055142/7.5/0551 | Cancelled | Not determined | None |
| Atorvastatin sun 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10 | 42055242/7.5/0552 | Registered | Not determined | None |
| Atorvastatin sun 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20 | 42055342/7.5/0553 | Registered | Not determined | None |
| Atorvastatin sun 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40 | 42055442/7.5/0554 | Registered | Not determined | None |
| Atorvastatin sun 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80 | 42055542/7.5/0555 | Registered | Not determined | None |
| Lipogen 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10/20/40/80 mgFilm coated tablets | 42055642/7.5/0556Approved 25 August 2023 | Registered | S4 | PIPIL |
| Lipogen 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 10/20/40/80 mgFilm coated tablets | 42055742/7.5/0557Approved 25 August 2023 | Registered | S4 | PIPIL |
| Lipogen 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 10/20/40/80 mgFilm coated tablets | 42055842/7.5/0558Approved 25 August 2023 | Registered | S4 | PIPIL |
| Lipogen 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 10/20/40/80 mgFilm coated tablets | 42055942/7.5/0559Approved 25 August 2023 | Registered | S4 | PIPIL |
| Atorvastatin 10 unimed EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10 | 42092642/7.5/0926 | Registered | Not determined | None |
| Atorvastatin 20 unimed EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20 | 42092742/7.5/0927 | Registered | Not determined | None |
| Atorvastatin 40 unimed EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40 | 42092842/7.5/0928 | Registered | Not determined | None |
| Atorvastatin 80 unimed EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80 | 42092942/7.5/0929 | Registered | Not determined | None |
| Orbeos 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10 | 42105042/7.5/1050 | Cancelled | Not determined | None |
| Orbeos 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20 | 42105142/7.5/1051 | Cancelled | Not determined | None |
| Orbeos 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40 | 42105242/7.5/1052 | Cancelled | Not determined | None |
| Dynator 10 MG EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10 mg | 43016743/7.5/0167 | Registered | Not determined | None |
| Dynator 20 MG EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20 mg | 43016843/7.5/0168 | Registered | Not determined | None |
| Dynator 40 MG EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40 mg | 43016943/7.5/0169 | Registered | Not determined | None |
| Dynator 80 MG EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80 mg | 43017043/7.5/0170 | Registered | Not determined | None |
| Atorvastatin 10 viatris EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10Tablet | 43022243/7.5/0222Approved 13 September 2025 | Registered | S4 | PIPIL |
| Atorvastatin 20 viatris EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20Tablet | 43022343/7.5/0223Approved 13 September 2025 | Registered | S4 | PIPIL |
| Atorvastatin 40 viatris EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40Tablet | 43022443/7.5/0224Approved 13 September 2025 | Registered | S4 | PIPIL |
| Atorvastatin winthrop 10 MG EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10 mg | 43048043/7.5/0480 | Cancelled | Not determined | None |
| Atorvastatin winthrop 20 MG EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20 mg | 43048143/7.5/0481 | Cancelled | Not determined | None |
| Atorvastatin winthrop 40 MG EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40 mg | 43048243/7.5/0482 | Cancelled | Not determined | None |
| Aspavor 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80Tablet | 43083743/7.5/0837Approved 5 October 2022 | Registered | S4 | PIPIL |
| Orbeos 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80 | 43083843/7.5/0838 | Cancelled | Not determined | None |
| Atorvastatin 80 viatris EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80Tablet | 43083943/7.5/0839Approved 13 September 2025 | Registered | S4 | PIPIL |
| Restan-atorvastatin 10 MG EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10 mg | 43111343/7.5/1113 | Cancelled | Not determined | None |
| Restan-atorvastatin 20 MG EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20 mg | 43111443/7.5/1114 | Cancelled | Not determined | None |
| Restan-atorvastatin 40 MG EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40 mg | 43111543/7.5/1115 | Cancelled | Not determined | None |
| Adco atorvastatin 10 MG EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10 mg | 43111643/7.5/1116 | Cancelled | Not determined | None |
| Adco atorvastatin 20 MG EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20 mg | 43111743/7.5/1117 | Cancelled | Not determined | None |
| Adco atorvastatin 40 MG EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40 mg | 43111843/7.5/1118 | Cancelled | Not determined | None |
| Alcholtin 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10 | 43111943/7.5/1119 | Cancelled | Not determined | None |
| Alcholtin 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20 | 43112043/7.5/1120 | Cancelled | Not determined | None |
| Alcholtin 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40 | 43112143/7.5/1121 | Cancelled | Not determined | None |
| Astor 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10/20/40/80 mgFilm-coated tablets | 44105444/7.5/1054Approved 30 September 2025 | Registered | S4 | PIPIL |
| Astor 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 10/20/40/80 mgFilm-coated tablets | 44105544/7.5/1055Approved 30 September 2025 | Registered | S4 | PIPIL |
| Astor 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 10/20/40/80 mgFilm-coated tablets | 44105644/7.5/1056Approved 30 September 2025 | Registered | S4 | PIPIL |
| Astor 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 10/20/40/80 mgFilm-coated tablets | 44105744/7.5/1057Approved 30 September 2025 | Registered | S4 | PIPIL |
| Lestavor 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10Film-coated tablets | 44105844/7.5/1058Approved 13 December 2023 | Registered | Not determined | PIPIL |
| Lestavor 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20Film-coated tablets | 44105944/7.5/1059Approved 13 December 2023 | Registered | Not determined | PIPIL |
| Lestavor 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40Film-coated tablets | 44106044/7.5/1060Approved 13 December 2023 | Registered | Not determined | PIPIL |
| Lestavor 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80Film-coated tablets | 44106144/7.5/1061Approved 13 December 2023 | Registered | Not determined | PIPIL |
| Atorvastatin LHC 10 EACH TABLET CONTAINS : ATORVASTATIN 10,0 mg | 10Tablets | 45044745/7.5/0447Approved 10 September 2023 | Registered | Not determined | PIPIL |
| Atorvastatin LHC 20 EACH TABLET CONTAINS : ATORVASTATIN 20,0 mg | 20Tablets | 45044845/7.5/0448Approved 10 September 2023 | Registered | Not determined | PIPIL |
| Vastor 10 MG EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10 mg | 45052745/7.5/0527 | Registered | Not determined | None |
| Vastor 20 MG EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20 mg | 45052845/7.5/0528 | Registered | Not determined | None |
| Vastor 40 MG EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40 mg | 45052945/7.5/0529 | Registered | Not determined | None |
| Vastor 80 MG EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 80 mg | 45053045/7.5/0530 | Registered | Not determined | None |
| Dezzolip 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10mg/20mg/40mg/80mgFilm coated tablet | 48120248/7.5/1202Approved 30 June 2022 | Registered | S4 | PIPIL |
| Dezzolip 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 10mg/20mg/40mg/80mgFilm coated tablet | 48120348/7.5/1203Approved 30 June 2022 | Registered | S4 | PIPIL |
| Dezzolip 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 10mg/20mg/40mg/80mgFilm coated tablet | 48120448/7.5/1204Approved 30 June 2022 | Registered | S4 | PIPIL |
| Dezzolip 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 10mg/20mg/40mg/80mgFilm coated tablet | 48120548/7.5/1205Approved 30 June 2022 | Registered | S4 | PIPIL |
| Alipto 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10/ 20/ 40/ 80mgFilm-coated tablets | 48120648/7.5/1206Approved 21 June 2024 | Registered | Not determined | PIPIL |
| Alipto 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 10/ 20/ 40/ 80mgFilm-coated tablets | 48120748/7.5/1207Approved 21 June 2024 | Registered | Not determined | PIPIL |
| Alipto 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 10/ 20/ 40/ 80mgFilm-coated tablets | 48120848/7.5/1208Approved 21 June 2024 | Registered | Not determined | PIPIL |
| Alipto 80 EACH TABLET CONTAINS ATORVASTATIN 80,0 mg | 10/ 20/ 40/ 80mgFilm-coated tablets | 48120948/7.5/1209Approved 21 June 2024 | Registered | Not determined | PIPIL |
| Xalipmin 10 | 10/20/40/80 mgFilm-coated tablets | 49047749/7.5/0477Approved 28 July 2025 | Registered | S4 | PIPIL |
| Xalipmin 20 | 10/20/40/80 mgFilm-coated tablets | 49047849/7.5/0478Approved 28 July 2025 | Registered | S4 | PIPIL |
| Xalipmin 40 | 10/20/40/80 mgFilm-coated tablets | 49047949/7.5/0479Approved 28 July 2025 | Registered | S4 | PIPIL |
| Xalipmin 80 | 10/20/40/80 mgFilm-coated tablets | 49048049/7.5/0480Approved 28 July 2025 | Registered | S4 | PIPIL |
| Cholmin 10 | 0/20/40/80 mgFilm-coated tablets | 49048149/7.5/0481Approved 28 July 2025 | Registered | S4 | PIPIL |
| Cholmin 20 | 0/20/40/80 mgFilm-coated tablets | 49048249/7.5/0482Approved 28 July 2025 | Registered | S4 | PIPIL |
| Cholmin 40 | 0/20/40/80 mgFilm-coated tablets | 49048349/7.5/0483Approved 28 July 2025 | Registered | S4 | PIPIL |
| Cholmin 80 | 0/20/40/80 mgFilm-coated tablets | 49048449/7.5/0484Approved 28 July 2025 | Registered | S4 | PIPIL |
| Lipred 10 | 10/20/40/80 mgFilm-coated tablets | 49048549/7.5/0485Approved 28 July 2025 | Registered | S4 | PIPIL |
| Lipred 20 | 10/20/40/80 mgFilm-coated tablets | 49048649/7.5/0486Approved 28 July 2025 | Registered | S4 | PIPIL |
| Lipred 40 | 10/20/40/80 mgFilm-coated tablets | 49048749/7.5/0487Approved 28 July 2025 | Registered | S4 | PIPIL |
| Lipred 80 | 10/20/40/80 mgFilm-coated tablets | 49048849/7.5/0488Approved 28 July 2025 | Registered | S4 | PIPIL |
| Atorvastatin 10 MG alkem EACH TABLET CONTAINS ATORVASTATIN CALCIUM EQUIVALENT TO ATORVASTATIN 10,0 mg | 10 mg | 55060855/7.5/0608 | Registrered | Not determined | None |
| Atorvastatin 20 MG alkem EACH TABLET CONTAINS ATORVASTATIN CALCIUM EQUIVALENT TO ATORVASTATIN 20,0 mg | 20 mg | 55060955/7.5/0609 | Registrered | Not determined | None |
| Atorvastatin 40 MG alkem EACH TABLET CONTAINS ATORVASTATIN CALCIUM EQUIVALENT TO ATORVASTATIN 40,0 mg | 40 mg | 55061055/7.5/0610 | Registrered | Not determined | None |
| Atorvastatin 80 MG alkem EACH TABLET CONTAINS ATORVASTATIN CALCIUM EQUIVALENT TO ATORVASTATIN 80,0 mg | 80 mg | 55061155/7.5/0611 | Registrered | Not determined | None |
| Aspavor 10 EACH TABLET CONTAINS ATORVASTATIN 10,0 mg | 10Tablet | A390017A39/7.5/0017Approved 5 October 2022 | Registered | S4 | PIPIL |
| Aspavor 20 EACH TABLET CONTAINS ATORVASTATIN 20,0 mg | 20Tablet | A390018A39/7.5/0018Approved 5 October 2022 | Registered | S4 | PIPIL |
| Aspavor 40 EACH TABLET CONTAINS ATORVASTATIN 40,0 mg | 40Tablet | A390019A39/7.5/0019Approved 5 October 2022 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Atorvastatin calcium equivalent to atorvastatin
S4: Atorvastatin
Consolidated Schedules 06 July 2026, line 5376
S4: Ezetimibe
Consolidated Schedules 06 July 2026, line 6302
Pharmacological class: Serum-cholesterol reducers. (class 7.5)
Matched through the component Ezetimibe.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Lipitor 20, Viatris Healthcare (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.